Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer-Reference-Cited by-同舟云学术

Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer

Author:

Liu Xuemei¹,Yin Zhiping²,Wu Yanjun³,Zhan Qian²,Huang Honghong⁴^ORCID,Fan Jiangtao⁵

Affiliation:

1. Department of Gynaecology and Obstetrics, Jinan City People’s Hospital, Jinan, China

2. Department of Laboratory Medicine, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, China

3. Department of Gynaecology and Obstetrics, Liaocheng People’s Hospital, Liaocheng, China

4. Department of Pharmacy, Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi, China

5. Department of Gynecology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

Funder

funding

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

Reference34 articles.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Roles and mechanisms of CircRNAs in ovarian cancer;Frontiers in Cell and Developmental Biology;2022-11-23